Therapeutic effect of systemic use of glatiramer acetate in imiquimod-induced mouse psoriasis model.

Journal: Cutaneous and ocular toxicology
Published Date: May 12, 2025

Abstract

PURPOSE: The aim of this study is to evaluate the therapeutic potential of systemic glatiramer acetate (GA), a drug used in the treatment of multiple sclerosis (MS), in an imiquimod-induced psoriasis mouse model, given the common immunopathogenic mechanisms between the two diseases.

Authors

  • Goknur Demiran
    Burhaniye State Hospital, Balıkesir, Turkey.
  • Rukiye Yasak Guner
    Dermatology Department, Cumhuriyet University School of Medicine, Sivas, Turkey.
  • Mustafa Ozkara
    Faculty of Veterinary Medicine, Department of Pathology, Cumhuriyet University, Sivas, Turkey.
  • Mustafa Tosun
    Dermatology Department, Cumhuriyet University School of Medicine, Sivas, Turkey.
  • Melih Akyol
    Dermatology Department, Cumhuriyet University School of Medicine, Sivas, Turkey.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals